What we do PI Industries Ltd is a leading Indian agri-sciences company specializing in crop protection chemicals, custom synthesis, and life sciences with strong domestic and global presence. |
Founded in 1,946 |
Market share Among the top 3 global players in AgChem custom synthesis with market-leading proprietary brands and expanding biologicals portfolio. |
Problem solved Addresses global challenges in agriculture by providing innovative crop protection, biological products, and specialty chemicals to enhance farm productivity sustainably. |
Top clients or who we serve Serves farmers, agri-input businesses, pharmaceutical and specialty chemical clients worldwide; operates B2B and B2C segments including branded domestic and export markets. |
Key management - |
Our journey and innovations Founded in 1946, expanded into integrated R&D, acquired global firms, pioneered new molecules, and adopted digital and green technologies for sustainable growth. |
Where we operate Operations in India, Asia (excluding India), North America, Europe, and Rest of the World with growing manufacturing and marketing footprints. |
Top products or what we offer Manufactures and markets crop protection chemicals, biologicals, pharmaceutical intermediates, electronic chemicals, and specialty products. |
Top brands Flagship AgChem brands include PRESSEDO, SOLJU, DORITO, BYROCK among others; known for product innovation and market leadership. |
Raw materials needed Key raw materials include chemical intermediates and specialized agrochemical ingredients sourced globally for manufacturing. |
Raw materials supplier Suppliers include diverse international and domestic chemical raw material providers ensuring supply chain resilience. |
Recurring vs cyclical contribution Revenue is a mix of recurring sales from proprietary branded products and cyclical custom synthesis orders tied to innovation cycles. |
Our industry position Market leader in agrochemical custom synthesis in India with expanding presence in life sciences and specialty chemicals globally. |
Financial highlights FY 2024-25 revenue at ₹75,712 million, Net Profit ₹18,665 million, EBITDA growth of 18.45% YoY, strong cash reserves over ₹39,800 million. |
Geographical revenue split Revenue split FY25: India ₹1,432 crore, Asia ex-India ₹3,773 crore, North America ₹1,682 crore, Europe ₹455 crore, Rest of World ₹636 crore. |
Order book - |
Whats driving growth Growth driven by new product launches, biologicals expansion, pharma CRDMO investments, advanced technologies, and global partnerships. |
Our future plans Plans include scaling biologicals fivefold, expanding pharma CRDMO, advancing R&D, increasing global presence, and pursuing strategic M&A. |
Our green promise Committed to sustainability with renewable energy use, reducing emissions, water recycling, waste minimization and Industry 4.0 adoption. |
Our people and values Strong employee base focused on innovation, diversity, inclusion, and a culture of agility, continuous improvement, and safety. |
Key challenges ahead Challenges include regulatory tightening, climate risks, price pressures, supply chain uncertainties, and global geopolitical volatility. |
Interesting facts First Indian company to gain ISO approval for insecticide Pioxaniliprole; recognized for top ESG ratings globally. |
Risks and strategy Mitigates risks through diversified portfolio, strong R&D pipeline, robust risk management framework, and strategic global collaborations. |
